文献速递骨肌MRCTDR

伯明翰非典型软骨肿瘤影像学方案(BACTIP)在美国单一三级医疗中心的回顾性验证

Retrospective validation of the Birmingham atypical cartilage tumor imaging protocol (BACTIP) in a single, United States tertiary care center.
PubMed 文献 · Skeletal Radiol · 2025-03-06

本研究在美国一家三级医疗中心回顾性验证BACTIP对成人肱骨近端、股骨远端和胫骨近端不确定中心性软骨肿瘤的评估效果。292例按BACTIP七分类归类后,IA和IB型最终诊断内生软骨瘤均为100%,IC型66%,IIB型50%;IIC型43%为中间或高级别软骨肉瘤,III型75%为去分化软骨肉瘤;恶性转化率0.3%,未发现BACTIP应用导致诊断延迟。

要点

  • BACTIP分型中IA和IB型最终诊断内生软骨瘤均为100%,IC型为66%,IIB型为50%。
  • IIC型病变中43%诊断为中间或高级别软骨肉瘤,III型病变中75%为去分化软骨肉瘤。
  • 本研究中恶性转化率为0.3%,未发现应用BACTIP导致诊断延迟的病例。

核心结论

  • 未发现应用BACTIP会导致诊断延迟的病例,BACTIP可作为肩关节和膝关节周围中心性软骨肿瘤患者保守且适当的影像随访指南。

研究设计与样本

  • 回顾性研究,通过健康网络PACS关键词检索纳入292例符合标准的成人肱骨近端、股骨远端和胫骨近端不确定中心性软骨肿瘤,依据大小和骨内膜扇贝样改变程度按BACTIP七分类归类。

诊断标准与关键数值

  • BACTIP基于病变大小和骨内膜扇贝样改变程度将病变分为七类。
  • IA和IB型最终诊断内生软骨瘤均为100%,IC型内生软骨瘤66%、非典型软骨肿瘤33%,IIB型内生软骨瘤50%、非典型软骨肿瘤50%。
  • IIC型病变中43%诊断为中间或高级别软骨肉瘤,III型病变中75%为去分化软骨肉瘤。

临床应用与阅片要点

  • BACTIP可作为肩关节和膝关节周围中心性软骨肿瘤患者保守且适当的影像随访指南。
  • 本研究中恶性转化率为0.3%,未发现应用BACTIP导致诊断延迟的病例。

局限性

  • 本研究为回顾性研究。
  • 本研究在单一美国三级医疗中心进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Central cartilage tumors are common incidental lesions around knee and shoulder joints. Differentiation of low-grade chondroid lesions, such as enchondroma from atypical cartilaginous tumor (ACT) is often difficult on imaging given pathologic and radiologic similarities. The Birmingham atypical cartilage tumor imaging protocol (BACTIP) provides a guide to initial assessment and imaging follow-up for incidental indeterminate central cartilage tumors.

OBJECTIVE: This study retrospectively evaluates BACTIP in a United States tertiary care center.

METHODS: Indeterminate central cartilage tumors in the proximal humerus, distal femur, and proximal tibia of adults were identified by a keyword search in the health network picture archiving and communications systems (PACS). These were categorized into one of seven BACTIP categories based on criteria including size and degree of endosteal scalloping.

RESULTS: There were 292 cases that met the inclusion criteria. The final diagnosis of enchondroma was 100% for lesion types IA and IB, 66% for IC, and 50% for IIB; ACT was 33% for IC and 50% for IIB. Of the type IIC lesions, 43% were diagnosed as intermediate or high-grade chondrosarcoma. Pathology diagnosis was dedifferentiated chondrosarcoma in 75% of type III lesions. Chart review and follow-up imaging revealed no delay of diagnosis. The malignant transformation rate in this study was 0.3%.

CONCLUSION: There were no cases where the application of BACTIP would have led to a delayed diagnosis. The BACTIP would serve as a conservative and appropriate imaging follow-up guideline for patients with central cartilage tumors around the shoulder and knee joint.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Opper S, Saucedo S, Ercolano L, et al. Retrospective validation of the Birmingham atypical cartilage tumor imaging protocol (BACTIP) in a single, United States tertiary care center. Skeletal Radiol. 2025. PMID: 40045048. doi:10.1007/s00256-025-04900-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。